Phase II Trial of Gleevec and Low-Dose Ara-C for Elderly Patients With C-Kit Positive Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes.
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Cytarabine; Imatinib
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 02 Jun 2007 New trial record.